Home EC4 European Syllabus for Post-Graduate Training in Clinical Chemistry and Laboratory Medicine: version 3 – 2005
Article
Licensed
Unlicensed Requires Authentication

EC4 European Syllabus for Post-Graduate Training in Clinical Chemistry and Laboratory Medicine: version 3 – 2005

  • Simone Zerah , Janet McMurray , Bernard Bousquet , Hannsjorg Baum , Graham H. Beastall , Vic Blaton , Marie-Josèphe Cals , Danielle Duchassaing , Marie-Françoise Gaudeau-Toussaint , Aimo Harmoinen , Hans Hoffmann , Rob T. Jansen , Desmond Kenny , Klaus P. Kohse , Ursula Köller , Jean-Gérard Gobert , Christine Linget , Erik Lund , Giuseppe Nubile , Matthias Opp , Mario Pazzagli , Georges Pinon , José M. Queralto , Henrique Reguengo , Demetrios Rizos , Thomas Szekeres , Michel Vidaud , Hans Wallinder and European Communities of Clinical Chemistry, EC4 Register Commission
Published/Copyright: September 21, 2011

Abstract

The EC4 Syllabus for Postgraduate Training is the basis for the European Register of Specialists in Clinical Chemistry and Laboratory Medicine.

The syllabus:

  • Indicates the level of requirements in postgraduate training to harmonise the postgraduate education in the European Union (EU);

  • Indicates the level of content of national training programmes to obtain adequate knowledge and experience;

  • Is approved by all EU societies for clinical chemistry and laboratory medicine.

The syllabus is not primarily meant to be a training guide, but on the basis of the overview given (common minimal programme), national societies should formulate programmes that indicate where knowledge and experience is needed.

The main points of this programme are:

  • Indicates the level of requirements in postgraduate training to harmonise the postgraduate education in the European Union (EU);

  • Indicates the level of content of national training programmes to obtain adequate knowledge and experience;

  • Is approved by all EU societies for clinical chemistry and laboratory medicine.

  • Knowledge in biochemistry, haematology, immunology, etc.;

  • Pre-analytical conditions;

  • Evaluation of results;

  • Interpretations (post-analytical phase);

  • Laboratory management; and

  • Quality insurance management.

The aim of this version of the syllabus is to be in accordance with the Directive of Professional Qualifications published on 30 September 2005.

To prepare the common platforms planned in this directive, the disciplines are divided into four categories:

  • Indicates the level of requirements in postgraduate training to harmonise the postgraduate education in the European Union (EU);

  • Indicates the level of content of national training programmes to obtain adequate knowledge and experience;

  • Is approved by all EU societies for clinical chemistry and laboratory medicine.

  • Knowledge in biochemistry, haematology, immunology, etc.;

  • Pre-analytical conditions;

  • Evaluation of results;

  • Interpretations (post-analytical phase);

  • Laboratory management; and

  • Quality insurance management.

  • General chemistry, encompassing biochemistry, endocrinology, chemical (humoral), immunology, toxicology, and therapeutic drug monitoring;

  • Haematology, covering cells, transfusion serology, coagulation, and cellular immunology;

  • Microbiology, involving bacteriology, virology, parasitology, and mycology;

  • Genetics and IVF.


Corresponding author: Dr. Simone Zerah, Laboratoire d'analyses de biologie médicale, 7 rue Raymond Lefebvre, 93170 Bagnolet, France, SFBC, EC4 Register Committee, Bagnolet, France

Published Online: 2011-9-21
Published in Print: 2006-1-1

©2006 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Where does the evidence come from?
  2. NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancer
  3. Plasma cell-free DNA as an indicator of severity of injury in burn patients
  4. Bivariate statistical approach to evaluate laboratory performance by analysis of standard curves in an External Quality Assurance program for quantitative assays based on real-time PCR with Taq-Man™ probes
  5. Erythrocyte membrane acetylcholinesterase activity in subjects with MTHFR 677C→T genotype
  6. Plasma levels of tumor M2-pyruvate kinase should not be used as a tumor marker for hematological malignancies and solid tumors
  7. APO A-V–1131T→C polymorphism frequency and its association with morbidity in a Brazilian elderly population
  8. Association study between fibronectin and coronary heart disease
  9. Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins
  10. Urinary calcium excretion in severe preeclampsia and eclampsia
  11. In vitro re-mineralization of demineralized bone matrix in human serum
  12. Measurement of serum amyloid A1 (SAA1), a major isotype of acute phase SAA
  13. Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure
  14. Measurement of serum testosterone using high-performance liquid chromatography/tandem mass spectrometry
  15. Quantitative bacterial micro-assay for rapid detection of serum phenylalanine on dry blood-spots: application in phenylketonuria screening
  16. N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability
  17. A new quality control model using performance goals based on biological variation in External Quality Assurance Schemes
  18. Improvement in glycemic control over 11 years in patients monitored for diabetes in one county
  19. The clinical usefulness of glucose tolerance testing in gestational diabetes to predict early postpartum diabetes mellitus
  20. Analytical performance of a new two-step ADVIA Centaur® estradiol immunoassay during ovarian stimulation
  21. EC4 European Syllabus for Post-Graduate Training in Clinical Chemistry and Laboratory Medicine: version 3 – 2005
  22. POX-Act assay and d-ROMs test – what are the facts?
  23. External quality control of urinary methyl malonic acid quantification – announcement of a pilot study
Downloaded on 20.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2006.021/html?lang=en
Scroll to top button